Medical specialists from United Kingdom tagged as investigators in clinical trials studying Prostatic Neoplasms, Castration-Resistant
Total 13 results
-
Andrew ClampSeen in:
- Manchester, The Christie NHS Foundation Trust, Department of Medical Oncology
Trials:- NCT04104776 (Principal Investigator)
-
Anna Minchom, MB, BCh, MRCP, MDSeen in:
- Surrey, Sutton, Royal Marsden Hospital
Trials:- NCT02998567 (Principal Investigator)
-
Dionysis Papadatos-Pastos, FRCPSeen in:
- London, UCLH
Trials:- NCT02998567 (Principal Investigator)
-
Emma CattellSeen in:
- Taunton, Musgrove Park Hospital
Trials:- NCT04104776 (Principal Investigator)
-
Emma GraySeen in:
- Taunton, Musgrove Park Hospital
Trials:- NCT05848011 (Principal Investigator)
Conditions: -
Harriet Walter, MDSeen in:
- Leicester, University Hospitals of Leicester NHS Trust
Trials:- NCT04104776 (Principal Investigator)
-
Johann de BonoSeen in:
- Surrey, London, Royal Marsden Hospital
- Surrey, Sutton, The Royal Marsden NHS Trust
- Sutton, Royal Marsden Hospital
Trials:- NCT04839991 (Principal Investigator)
- NCT05848011 (Principal Investigator)
- NCT05551117 (Principal Investigator)
Conditions:- Advanced and/or Metastatic Solid Tumours;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule;
- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Anal Neoplasm
-
Mark TuthillSeen in:
- Headington, Churchill Hospital
- Oxford, Oxford University Hospitals NHS Foundation Trust
- Oxford, Oxford University Hospitals NHS- Churchill Hospital
Trials:- NCT05104515 (Principal Investigator)
- NCT05848011 (Principal Investigator)
- NCT05551117 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Prostate Cancer;
- Non Small Cell Lung Cancer;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule;
- Melanoma;
- Non-small Cell Lung Cancer;
- Small-cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Anal Cancer;
- Malignant Melanoma;
- Non-small Cell Carcinoma;
- Oral Squamous Cell Carcinoma;
- Small Cell Carcinoma;
- Laryngeal Squamous Cell Carcinoma;
- Carcinoma, Squamous Cell of Head and Neck;
- Castration-Resistant Prostatic Cancer;
- Androgen-Insensitive Prostatic Cancer;
- Anal Neoplasm
-
Naveed SarwarSeen in:
- Hammersmith And Fulham, London, Charing Cross Hospital
- London, Charing Cross Hospital
- London, Imperial College Healthcare NHS Trust
Trials:- NCT04691804 (Principal Investigator)
- NCT05288166 (Principal Investigator)
- NCT03288532 (Principal Investigator)
- NCT05848011 (Principal Investigator)
Conditions:- Metastatic Castration-Resistant Prostate Cancer (mCRPC);
- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Renal Cell Carcinoma;
- Prostate Cancer Recurrent;
- Immunotherapy;
- Androgen-Independent Prostatic Cancer;
- Androgen-Resistant Prostatic Cancer;
- Hormone Refractory Prostatic Cancer;
- Immune Checkpoint Inhibitor;
- Androgen-Independent Prostatic Neoplasms;
- Androgen-Insensitive Prostatic Cance;
- Inhibitory Checkpoint Molecule
-
Rebecca BowenSeen in:
- Bath, Royal United Hospital
Trials:- NCT04104776 (Principal Investigator)
-
Susana BanerjeeSeen in:
- London, City Of, London, The Royal Marsden NHS Foundation Trust
- London, City Of, Sutton, The Royal Marsden NHS Foundation Trust
- London, The Royal Marsden NHS Foundation Trust
- Surrey, Sutton, The Royal Marsden NHS Foundation Trust
- Sutton, Royal Marsden Hospital - Sutton
Trials:- NCT05483933 (Principal Investigator)
- NCT05456685 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Ovarian Cancer;
- Fallopian Tube Cancer;
- Epithelial Ovarian Cancer;
- Platinum-resistant Ovarian Cancer;
- Primary Peritoneal Carcinoma;
- Platinum-Resistant Fallopian Tube Carcinoma;
- Platinum-Resistant Primary Peritoneal Carcinoma;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
Clinical Trials on Prostatic Neoplasms, Castration-Resistant
-
Australian and New Zealand Urogenital and Prostate...Peter MacCallum Cancer Centre, AustraliaRecruitingCastration Resistant Prostatic CancerAustralia
-
University Hospital, GrenobleTerminatedCastration-resistant Prostate CancerFrance
-
Nuvation Bio Inc.WithdrawnProstate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Castrate Resistant Prostate Cancer | Cancer of Prostate | Castration Resistant Prostatic Cancer | Castration Resistant Prostatic NeoplasmsUnited States
-
British Columbia Cancer AgencySanofi; Ozmosis Research Inc.UnknownMetastatic Castration-Resistant Prostatic CancerCanada, Australia
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Janux TherapeuticsRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic CancerUnited States, Australia
-
Universität des SaarlandesRecruitingProstate Cancer Metastatic | Advanced Prostate Carcinoma | Castration Resistant Prostatic CancerGermany
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingProstate Cancer | Refractory Cancer | Castration Resistant Prostatic CancerUnited States
-
Yinghao SunNot yet recruitingCastration-Resistant Prostatic Cancer